SWOBY Financials

Swedish Orphan Biovitrum AB (publ) - Financial statements & key metrics

Stock Price

$20.87

Market Cap

$15.10B

P/E Ratio

260.9

EPS

$0.08

Income Statement Highlights

Most Recent Quarter: 2025-12-31

Revenue

$28.24B

Gross Profit

$21.99B

Operating Income

$922.00M

Net Income

$478.00M

EPS (Diluted)

Balance Sheet Highlights

Total Assets

$67.43B

Total Liabilities

$29.71B

Shareholders Equity

$37.72B

Cash & Equivalents

$1.04B

Total Debt

Cash Flow Highlights

Operating Cash Flow

$8.56B

CapEx

$3.15B

Free Cash Flow

$5.41B

Profitability Metrics

Gross Margin

78.2%

Net Margin

0.0%

ROE

0.0%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is SWOBY revenue?

SWOBY's most recent quarterly revenue was $28.24B. Annual revenue can be calculated by summing the four most recent quarters.

Is SWOBY profitable?

SWOBY reported a profit of $478.00M in the most recent quarter. The net profit margin is 0.0%.

What is SWOBY market cap?

SWOBY has a market capitalization of $15.10B, making it a large-cap stock.

Does SWOBY have debt?

View SWOBY's balance sheet for debt information.

What is SWOBY cash flow?

SWOBY's most recent quarterly free cash flow was $5.41B.